Geron Net Worth
Geron Net Worth Breakdown | GERN |
Geron Net Worth Analysis
Geron's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Geron's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Geron's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Geron's net worth analysis. One common approach is to calculate Geron's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Geron's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Geron's net worth. This approach calculates the present value of Geron's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Geron's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Geron's net worth. This involves comparing Geron's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Geron's net worth relative to its peers.
Enterprise Value |
|
To determine if Geron is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Geron's net worth research are outlined below:
| Geron generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 237 K. Net Loss for the year was (184.13 M) with loss before overhead, payroll, taxes, and interest of (93.67 M). | |
| Geron currently holds about 219.29 M in cash with (167.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Geron has a frail financial position based on the latest SEC disclosures | |
| Over 85.0% of the company shares are owned by institutional investors | |
| Latest headline from insidermonkey.com: Geron Corp. Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts |
Geron uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Geron. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Geron's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Geron's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Geron is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Geron backward and forwards among themselves. Geron's institutional investor refers to the entity that pools money to purchase Geron's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wellington Management Company Llp | 2024-06-30 | 12.1 M | Goldman Sachs Group Inc | 2024-06-30 | 11.3 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 11.3 M | Jefferies Financial Group Inc | 2024-09-30 | 9.7 M | Hhg Plc | 2024-06-30 | 9.4 M | Orbimed Advisors, Llc | 2024-06-30 | 8.9 M | Millennium Management Llc | 2024-06-30 | 7.7 M | Deep Track Capital, Lp | 2024-09-30 | 7.6 M | Eventide Asset Management, Llc | 2024-09-30 | 7.1 M | Blackrock Inc | 2024-06-30 | 46.6 M | Vanguard Group Inc | 2024-09-30 | 32.4 M |
Follow Geron's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.46 B.Market Cap |
|
Project Geron's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.47) | (0.49) | |
| Return On Capital Employed | (0.68) | (0.71) | |
| Return On Assets | (0.47) | (0.49) | |
| Return On Equity | (0.74) | (0.78) |
When accessing Geron's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Geron's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Geron's profitability and make more informed investment decisions.
Evaluate Geron's management efficiency
Geron has return on total asset (ROA) of (0.303) % which means that it has lost $0.303 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6903) %, meaning that it created substantial loss on money invested by shareholders. Geron's management efficiency ratios could be used to measure how well Geron manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to drop to -0.49. In addition to that, Return On Capital Employed is likely to drop to -0.71. At this time, Geron's Total Assets are very stable compared to the past year. As of the 25th of November 2024, Non Current Assets Total is likely to grow to about 55.4 M, while Non Currrent Assets Other are likely to drop about 4.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.43 | 0.41 | |
| Tangible Book Value Per Share | 0.43 | 0.41 | |
| Enterprise Value Over EBITDA | (6.97) | (6.62) | |
| Price Book Value Ratio | 4.86 | 2.86 | |
| Enterprise Value Multiple | (6.97) | (6.62) | |
| Price Fair Value | 4.86 | 2.86 | |
| Enterprise Value | 1.2 B | 1.3 B |
The strategic initiatives led by Geron's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 74.8917 | Revenue 29.5 M | Quarterly Revenue Growth 171.384 | Revenue Per Share 0.047 | Return On Equity (0.69) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Geron insiders, such as employees or executives, is commonly permitted as long as it does not rely on Geron's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Geron insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Geron Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 12th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 27th of March 2024 Other Reports | ViewVerify |
Geron Earnings per Share Projection vs Actual
Geron Corporate Management
| Andrew Grethlein | Executive VP of Devel. and Technical Operations | Profile | |
| Faye MD | Executive Officer | Profile | |
| Stephen JD | Chief VP | Profile | |
| Aron Feingold | Vice Communications | Profile | |
| James MBA | Executive Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share 0.047 | Quarterly Revenue Growth 171.384 | Return On Assets (0.30) | Return On Equity (0.69) |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.